Silo Pharma, Inc.
SILO
$0.63
-$0.011-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.03M | -1.73M | -928.80K | -931.80K | -801.70K |
| Total Depreciation and Amortization | 3.10K | 3.10K | 3.10K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.90K | 0.00 | 0.00 | 1.30K | -200.00 |
| Change in Net Operating Assets | -609.00K | 810.10K | -420.80K | 198.70K | -36.30K |
| Cash from Operations | -1.64M | -917.40K | -1.35M | -731.80K | -838.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 871.40K | -37.70K | -40.40K | 954.30K | 97.60K |
| Cash from Investing | 871.40K | -37.70K | -40.40K | 954.30K | 97.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 1.74M | 1.67M | -- |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -57.70K | -115.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 1.74M | 1.62M | -115.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -768.90K | -955.10K | 354.60K | 1.84M | -856.00K |